Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Annales De Chirurgie Plastique Et Esthetique|October 18, 2015
[Large surgical resection of a shoulder sarcoma's and secure one stage reconstruction with lattissimi dorsi and serratus anterior flap. Updating about a case]J Haddad, F Gouailler, E Aleton, et al.
Annales De Chirurgie Plastique Et Esthetique|October 26, 2016
[Evaluation of the management of soft tissue sarcomas in Franche-Comté since the establishment of a multidisciplinary meeting at University Hospital. About 47 cases]J Haddad, E Kalbacher, M Piccard, et al.
Investigational New Drugs|September 6, 2013
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)T Valentin, C Fournier, N Penel, et al.
Journal of Surgical Oncology|November 22, 2005
Radiation and chemoradiation therapy for esophageal adenocarcinomaJean-François Bosset, F Lorchel, G Mantion, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
[Hepar lobatum carcinomatusum: a rare cause of portal hypertension complicating hepatic metastases in breast cancer]J-P Cervoni, A Dobrin, N Sailley, et al.
Breast (Edinburgh, Scotland)|March 29, 2011
Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trialC Villanueva, L Chaigneau, A Dufresne, et al.
Gynecologic Oncology|November 6, 2007
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancerA Goncalves, M Fabbro, C Lhommé, et al.
Journal of Medical Case Reports|August 18, 2021
Humeral metastasis as the only recurrence of a 5-year resected gastrointestinal stromal tumor: a case reportC Braunstein, F Sirveaux, E Kalbacher, et al.
Breast (Edinburgh, Scotland)|November 30, 2011
Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapyN Chaumard, S Limat, C Villanueva, et al.
Targeted Oncology|April 24, 2013
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06C Villanueva, G Romieu, J Salvat, et al.
Pageof 3